Ron Bentsur - 01 Sep 2022 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chairman & CEO, Director, 10%+ Owner
Signature
/s/ Ron Bentsur
Issuer symbol
NVCT
Transactions as of
01 Sep 2022
Net transactions value
+$14,099
Form type
4
Filing time
06 Sep 2022, 08:00:50 UTC
Previous filing
30 Aug 2022
Next filing
27 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $4,055 +500 +0.02% $8.11 3,009,409 01 Sep 2022 Direct F1
transaction NVCT Common Stock Purchase $10,044 +1,200 +0.04% $8.37 3,010,609 02 Sep 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 96,759 shares of restricted stock and 120,000 restricted stock units.